Chronic pain can also lead to anxiety and depression as brain inflammation caused by long-term nerve pain alters activity in areas that regulate mood and motivation, says new research.
This finding published online in the Journal of Neuroscience could lead to new approaches for treating chronic pain.
"For over 20 years, scientists have been trying to unlock the mechanisms at work that connect opioid use, pain relief, depression and addiction," said one of the researchers Catherine Cahill, associate professor of anesthesiology & perioperative care at University of California, Irvine in the US.
"Our findings represent a paradigm shift which has broad implications that are not restricted to the problem of pain and may translate to other disorders," Cahill said.
In work with rodents, the researchers discovered that pain-derived brain inflammation causes the accelerated growth and activation of immune cells called microglia.
These cells trigger chemical signals within neurons that restrict the release of dopamine, a neurotransmitter that helps control the brain's reward and pleasure centers. The study also reveals why opioid drugs such as morphine can be ineffective against chronic pain.
Morphine and its derivatives normally stimulate the release of dopamine. But in research on mice and rats in chronic pain, Cahill and her colleagues learned that these drugs failed to stimulate a dopamine response, resulting in impaired reward-motivated behaviour.
"Treating these animals in chronic pain with a drug that inhibits microglial activation restored dopamine release and reward-motivated behaviour," Cahill added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
